Search

Your search keyword '"Gebo, Kelly A"' showing total 429 results

Search Constraints

Start Over You searched for: Author "Gebo, Kelly A" Remove constraint Author: "Gebo, Kelly A" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
429 results on '"Gebo, Kelly A"'

Search Results

2. Discordant performance of mpox serological assays

3. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study

5. Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study

6. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

7. Mpox in people with advanced HIV infection: a global case series

9. The All of Us Research Program: Data quality, utility, and diversity

10. Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

12. Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers

13. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities

14. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study

15. Accuracy of Provider Predictions of Viral Suppression Among Adolescents and Young Adults With HIV in an HIV Clinical Program.

16. Ending the HIV epidemic in the USA: an economic modelling study in six cities

18. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study

19. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies

20. Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.

21. Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005–2018: A Collaboration of Cohort Studies.

22. The association of a scholarly concentrations program with medical students' matched residencies.

23. Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox.

25. Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States

26. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers

27. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010

31. Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program.

32. Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine.

33. Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample.

37. Comparison of Risk and Age at Diagnosis of Myocardial Infarction, End-Stage Renal Disease, and Non-AIDS-Defining Cancer in HIV-Infected Versus Uninfected Adults

38. Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators

44. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.

46. Factors Associated With Retention Among Non–Perinatally HIV-Infected Youth in the HIV Research Network

47. Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America

48. Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001–2009

Catalog

Books, media, physical & digital resources